In this episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba sits down with Dr. Drew Pardoll, a pioneer in cancer immunology, to explore the breakthroughs reshaping cancer research. From harnessing the immune system and advancing protein, cell, and microbial engineering to launching biotech startups that translate discoveries into real treatments, Dr. Pardoll shares how innovation and collaboration are driving cures forward. Together, they also reflect on the vital role of young scientists, the importance of smarter clinical trials, and what’s next on the horizon for cancer patients worldwide.